These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24810775)

  • 1. Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement.
    Cumper SK; Ahle GM; Liebman LS; Kellner CH
    J ECT; 2014 Jun; 30(2):122-4. PubMed ID: 24810775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECT for Parkinson's disease.
    Popeo D; Kellner CH
    Med Hypotheses; 2009 Oct; 73(4):468-9. PubMed ID: 19660875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
    Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
    J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy in Parkinson's disease and other movement disorders.
    Faber R; Trimble MR
    Mov Disord; 1991; 6(4):293-303. PubMed ID: 1758447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electroconvulsive therapy in the treatment of Parkinson disease].
    Jeanneau A
    Encephale; 1993; 19(5):573-8. PubMed ID: 8306926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electric stimulation (ECT) in Parkinson disease].
    Dam H; Pakkenberg H; Bolwig TG
    Ugeskr Laeger; 1992 Jan; 154(4):183-7. PubMed ID: 1736441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitters and electroconvulsive therapy.
    Baldinger P; Lotan A; Frey R; Kasper S; Lerer B; Lanzenberger R
    J ECT; 2014 Jun; 30(2):116-21. PubMed ID: 24820941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Parkinsonism in depressed patients treated with ECT.
    Lebensohn ZM; Jenkins RB
    Am J Psychiatry; 1975 Mar; 132(3):283-5. PubMed ID: 1115272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature.
    Wilkins KM; Ostroff R; Tampi RR
    J Geriatr Psychiatry Neurol; 2008 Mar; 21(1):3-11. PubMed ID: 18287164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease.
    Anastasia A; de Erausquin GA; Wojnacki J; Mascó DH
    J Neurochem; 2007 Nov; 103(4):1542-52. PubMed ID: 17854351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.
    Holcomb HH; Sternberg DE; Heninger GR
    Biol Psychiatry; 1983 Aug; 18(8):865-73. PubMed ID: 6615944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electroconvulsive therapy in Parkinson disease. Description of three cases].
    Avila A; Sastre F; Cardona X; Maho P; Bello J; Sancho I
    Neurologia; 1997; 12(7):313-6. PubMed ID: 9432202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.
    Borisovskaya A; Bryson WC; Buchholz J; Samii A; Borson S
    Neurodegener Dis Manag; 2016 Apr; 6(2):161-76. PubMed ID: 27033556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease, depression, and ECT: a review and case study.
    Asnis G
    Am J Psychiatry; 1977 Feb; 134(2):191-5. PubMed ID: 835744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of electroconvulsive therapy in Parkinson's disease: A clinical trial.
    Afshari D; Shakeri J; Khodamoradi M; Abadi RNS; Rahkan J; Afshar Hezarkhani L
    Neurosci Lett; 2022 Feb; 772():136449. PubMed ID: 35026333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method to model electroconvulsive therapy in rats with increased construct validity and enhanced translational value.
    Theilmann W; Löscher W; Socala K; Frieling H; Bleich S; Brandt C
    J Psychiatr Res; 2014 Jun; 53():94-8. PubMed ID: 24607291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of electric stimulation and mesenchymal stem cells against Parkinson's disease.
    Yang C; Qiu Y; Qing Y; Xu J; Dai W; Hu X; Wu X
    Aging (Albany NY); 2020 Aug; 12(16):16062-16071. PubMed ID: 32836217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinsonian mechanism of electroconvulsive therapy in MPTP-lesioned non-human primates.
    Landau AM; Clark C; Jivan S; Doudet DJ
    Neurodegener Dis; 2012; 9(3):128-38. PubMed ID: 22327563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.